Further study suggests that expression of stem cell markers including Oct4, Sox2, Nanog, and CD44 are also significantly downregulated and epithelial-to-mesenchymal transition (EMT) is also suppressed after doxycycline treatment in breast cancer [17]. This evidence concerns the gene CD44 and breast carcinoma.